Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Platelet membrane glycoprotein polymorphisms do not influence the clinical expressivity of von Willebrand disease type 1.

Thrombosis and haemostasis - 1 Dec 2003

Pereira Jaime, Quiroga Teresa, Pereira M Elisa, Morales María, Goycoolea Manuela, Hidalgo Patricia, Prieto Carolina, Mezzano Diego

Abstract excerpt

Von Willebrand disease (VWD) is characterized by a significant variation in bleeding symptoms among patients with similar laboratory profiles and equivalent plasma levels of von Willebrand factor (VWF) activities. Considering the recent suggestion that platelet membrane glycoprotein polymorphisms (PltGPs) may play a role as modulators of thromboembolic or haemorrhagic diseases, we investigated the role of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hemorrhage

Share to Hemostasis

Share to Platelet Membrane Glycoproteins

Share to Polymorphism, Genetic

Share to Surveys and Questionnaires

Share to von Willebrand Diseases

Source

Identifiers

PMID: 14652648
DOI: 10.1160/TH03-03-0135

Genes

VWF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Platelet membrane glycoprotein polymorphisms do not influence the clinical expressivity of von Willebrand disease type 1.PMID 14652648Read ↗

Hemostatic gene polymorphisms and the prevalence of thrombotic complications in polycythemia vera and essential thrombocythemia.Semantic proximity Read ↗

Genotyping provides a reliable tool for the determination of the platelet antigen system HPA-1 in Glanzmann's thrombasthenia.Semantic proximity Read ↗

PLA1/A2 polymorphism of the platelet glycoprotein receptors IIIA in Behçet's disease.Semantic proximity Read ↗

Platelet degranulation and glycoprotein IIbIIIa opening are not related to bleeding phenotype in severe haemophilia A patients.Semantic proximity Read ↗

Inconsistency of association between type 1 von Willebrand disease phenotype and genotype in families identified in an epidemiological investigation.Semantic proximity Read ↗

Low incidence of paradoxical platelet activation by glycoprotein IIb/IIIa inhibitors.Semantic proximity Read ↗

The impact of bleeding history, von Willebrand factor and PFA-100(®) on the diagnosis of type 1 von Willebrand disease: results from the European study MCMDM-1VWD.Semantic proximity Read ↗

HPA-1 genotype in arterial thrombosis--role of HPA-1b polymorphism in platelet function.Semantic proximity Read ↗

Platelet GP IIIA polymorphism HPA-1 (PLA1/2) is associated with hypertension as the primary cause for end-stage renal disease in hemodialysis patients from Greece.Semantic proximity Read ↗

The PlA1/A2 polymorphism of platelet glycoprotein IIIa is not associated with deep venous thrombosis.Semantic proximity Read ↗

Glycoprotein Ib polymorphisms influence platelet plug formation under high shear rates.Semantic proximity Read ↗

No evidence for an influence of the human platelet antigen-1 polymorphism on the antiplatelet effects of glycoprotein IIb/IIIa inhibitors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.